Abstract
We retrospectively studied whether treatment with esomeprazole improved HbA1c levels in type 2 diabetic patients. We selected 21 patients who had been treated with esomeprazole for 11±3 months and 21 controls. HbA1c levels decreased in the esomeprazole-treated group. Our data indicate that proton pump inhibitors may improve glycaemic control in type 2 diabetic patients.
Original language | English |
---|---|
Journal | Diabetes Research and Clinical Practice |
Volume | 90 |
Issue number | 3 |
ISSN | 0168-8227 |
DOIs | |
Publication status | Published - 1 Dec 2010 |
Externally published | Yes |
Keywords
- Glycaemic control
- Proton pump inhibitors
- Treatment
- Type 2 diabetes